Researchers have identified the mechanism in the brain that is key to sensing glucose levels in the blood, linking it to both type 1 and type 2 diabetes.
It could lead to new treatment and even prevention of diabetes.
"We have discovered that the prolyl endopeptidase enzyme -- located in a part of the hypothalamus known as the ventromedial nucleus -- sets a series of steps in motion that control glucose levels in the blood," said lead author Sabrina Diano, a professor at Yale School of Medicine in the US.
The ventromedial nucleus contains cells that are glucose sensors. To understand the role of prolyl endopeptidase in this part of the brain, the researchers used mice that were genetically engineered with low levels of this enzyme.
They found that in absence of this enzyme (prolyl endopeptidase), mice had high levels of glucose in the blood and became diabetic.
This enzyme is important because it makes the neurons in this part of the brain sensitive to glucose, the study noted.
The neurons sense the increase in glucose levels and then tell the pancreas to release insulin, which is the hormone that maintains a steady level of glucose in the blood, preventing diabetes.
"Because of the low levels of endopeptidase, the neurons were no longer sensitive to increased glucose levels and could not control the release of insulin from the pancreas, and the mice developed diabetes," Diano added.
The study appeared in the journal Proceedings of the National Academies of Sciences.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
